High-throughput single-сell sequencing in cancer research
2022 · Signal Transduction and Targeted Therapy · 132 citations
https://doi.org/10.1038/s41392-022-00990-4
H
Han Chu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.0K
Citations
12
h-index
18
i10-index
Han Chu is an academic researcher from China Shenhua Energy (China). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Computational Drug Discovery Methods & Ferroptosis and cancer prognosis. The author has an h-index of 12, co-authored 45 publications.
ORCID: 0000-0002-4060-7160Papers by this author
worksIn silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation
2020 · Computational Biology and Chemistry · 16 citations
https://doi.org/10.1016/j.compbiolchem.2020.107328
Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts
2025 · Cancer Cell · 16 citations
https://doi.org/10.1016/j.ccell.2025.03.036
In silico design novel vibsanin B derivatives as inhibitor for heat shock protein 90 based on 3D-QSAR, molecular docking and molecular dynamics simulation
2019 · Journal of Biomolecular Structure and Dynamics · 11 citations
https://doi.org/10.1080/07391102.2019.1671900
ATACAmp: a tool for detecting ecDNA/HSRs from bulk and single-cell ATAC-seq data
2023 · BMC Genomics · 11 citations
https://doi.org/10.1186/s12864-023-09792-6
Additional file 1 of ATACAmp: a tool for detecting ecDNA/HSRs from bulk and single-cell ATAC-seq data
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24546952
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat